ArticleScientific reports2026

Reticulocalbin 3 as a novel biomarker for assessing liver disease severity and identifying decompensated status in cirrhosis.

Feng-Wei Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.